Meijing Wang Selected Research

Type I Tumor Necrosis Factor Receptors

1/2017	Regulation of myocardial stromal cell-derived factor 1α/CXCL12 by tumor necrosis factor signaling.
6/2010	TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia.
10/2008	TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways.
9/2008	Mechanisms of sex differences in TNFR2-mediated cardioprotection.
10/2007	Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production.
9/2007	Sex differences in endothelial STAT3 mediate sex differences in myocardial inflammation.
4/2007	Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1beta.
1/2007	Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1).
7/2006	Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meijing Wang Research Topics

Disease

37	Ischemia 01/2022 - 12/2003
22	Hypoxia (Hypoxemia) 08/2014 - 07/2004
16	Inflammation (Inflammations) 04/2022 - 12/2003
9	Reperfusion Injury 01/2022 - 01/2005
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2005
6	Sepsis (Septicemia) 04/2009 - 01/2005
5	Acute Lung Injury 07/2008 - 07/2005
4	Neoplasms (Cancer) 04/2022 - 04/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2003
4	Heart Diseases (Heart Disease) 01/2022 - 05/2006
4	Wounds and Injuries (Trauma) 07/2008 - 01/2005
4	Pulmonary Hypertension 07/2008 - 11/2005
3	Heart Failure 01/2022 - 09/2006
3	Myocardial Infarction 04/2009 - 08/2007
2	Migraine Disorders (Migraine) 11/2020 - 01/2020
2	Infarction (Infarctions) 11/2019 - 10/2009
2	Hypertrophy 01/2016 - 09/2006
2	Fibrosis (Cirrhosis) 01/2016 - 11/2015
2	Shock 10/2008 - 07/2008
2	Cardiomegaly (Heart Hypertrophy) 07/2008 - 09/2006
2	Burns 07/2008 - 01/2005
2	Endotoxemia 02/2006 - 05/2005
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022
1	Neuroinflammatory Diseases 01/2022
1	Cognitive Dysfunction 01/2022
1	Osteoarthritis 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Insulin Resistance 01/2020
1	Muscular Atrophy (Muscle Atrophy) 04/2019
1	Rheumatoid Arthritis 09/2018

Drug/Important Bio-Agent (IBA)

14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2009 - 12/2006
13	CytokinesIBA 10/2009 - 12/2004
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008 - 12/2004
11	Estrogens (Estrogen)FDA Link 11/2019 - 12/2003
9	Type I Tumor Necrosis Factor ReceptorsIBA 01/2017 - 07/2006
9	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2014 - 10/2006
7	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2017 - 07/2006
7	Testosterone (Sustanon)FDA Link 11/2010 - 12/2003
6	Conditioned Culture MediaIBA 01/2022 - 06/2007
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2006
6	Interleukin-6 (Interleukin 6)IBA 10/2009 - 12/2005
6	Messenger RNA (mRNA)IBA 03/2008 - 12/2004
6	p38 Mitogen-Activated Protein KinasesIBA 06/2007 - 01/2005
4	Estradiol (Delestrogen)FDA LinkGeneric 08/2014 - 05/2008
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2008 - 11/2005
4	EndotoxinsIBA 03/2008 - 12/2006
3	Tyrosine (L-Tyrosine)FDA Link 04/2022 - 01/2021
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2022 - 01/2021
3	Interleukin-18 (Interleukin 18)IBA 01/2020 - 07/2008
3	Phosphotransferases (Kinase)IBA 04/2019 - 08/2006
3	Estrogen Receptor betaIBA 07/2009 - 08/2008
3	Vasoconstrictor AgentsIBA 12/2008 - 07/2008
3	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 12/2008 - 01/2006
3	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2008 - 05/2005
3	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2007 - 11/2005
3	Caspase 3 (Caspase-3)IBA 06/2006 - 12/2005
2	Lovastatin (Mevacor)FDA LinkGeneric 01/2021 - 01/2021
2	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2021 - 01/2020
2	Thymidine Monophosphate (TMP)IBA 11/2020 - 01/2020
2	ferulic acid (sodium ferulate)IBA 11/2020 - 01/2020
2	tetramethylpyrazineIBA 11/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 04/2019 - 09/2018
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2016 - 01/2006
2	Estrogen ReceptorsIBA 08/2011 - 08/2008
2	Androgen Receptors (Androgen Receptor)IBA 08/2009 - 01/2005
2	Flutamide (Eulexin)FDA LinkGeneric 08/2009 - 01/2005
2	Estrogen Receptor alphaIBA 07/2009 - 06/2006
2	Type II Tumor Necrosis Factor ReceptorsIBA 09/2008 - 10/2007
2	Interleukin-1beta (Interleukin 1 beta)IBA 08/2008 - 12/2005
2	Mitogen-Activated Protein KinasesIBA 07/2008 - 12/2005
2	Interleukin-1 (Interleukin 1)IBA 03/2008 - 09/2005
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2008 - 08/2007
2	LipopolysaccharidesIBA 12/2006 - 12/2006
2	Ion Channels (Ion Channel)IBA 06/2006 - 07/2004
1	Imiquimod (Aldara)FDA LinkGeneric 04/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	UridineIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Uridine PhosphorylaseIBA 01/2022
1	SolutionsIBA 01/2022
1	Isoflurane FDA LinkGeneric 01/2022
1	notoginsenoside R1IBA 01/2022
1	Protein Tyrosine PhosphatasesIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	gastrodinIBA 01/2020
1	4-hydroxybenzyl alcoholIBA 01/2020
1	SHP099IBA 01/2020
1	Connexin 43 (Connexin43)IBA 11/2019
1	regorafenibIBA 04/2019
1	Sorafenib (BAY 43-9006)FDA Link 04/2019
1	sinomenineIBA 09/2018

Therapy/Procedure

9	Therapeutics 01/2021 - 07/2004
2	Heart Transplantation (Grafting, Heart) 01/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2021 - 04/2019
2	Oral Administration 11/2020 - 01/2020
2	Baths 01/2006 - 11/2005
1	Transplantation 01/2022